Cannasouth Limited

Cannasouth Limited Share · NZCBDE0009S6 (XNZE) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Cannasouth Limited
No Price
Share Float & Liquidity
Free Float 99,18 %
Shares Float 327,77 M
Shares Outstanding 330,47 M
Company Profile for Cannasouth Limited Share
Cannasouth Limited, a biopharmaceutical company, engages in the research, development, manufacture, and supply of cannabinoid medicines and cannabis biomass in New Zealand. The company was incorporated in 2018 and is based in Hamilton, New Zealand.

Company Data

Name Cannasouth Limited
Company Cannasouth Limited
Website https://www.cannasouth.co.nz
Primary Exchange XNZE NZX
ISIN NZCBDE0009S6
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mark John Lucas
Market Capitalization 32 Mio
Country New Zealand
Currency NZD
Employees 0,0 T
Address CRV Building, 3216 Hamilton
IPO Date 2019-06-18

Stock Splits

Date Split
20.11.2023 51:50
19.08.2022 44:43

Ticker Symbols

Name Symbol
NZX CBD.NZ
More Shares
Investors who hold Cannasouth Limited also have the following shares in their portfolio:
CITY OF GOTHENBURG FLTG RTE NTS 25/09/23
CITY OF GOTHENBURG FLTG RTE NTS 25/09/23 Bond
ZKH Group Limited American Depositary Shares, each representing thirty-five (35) Class A Ordinary Shares
ZKH Group Limited American Depositary Shares, each representing thirty-five (35) Class A Ordinary Shares Depository Receipt